1Junghans U,Seitz RJ,Aulich A,et al.Bleeding risk of tirofiban:A nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke:An open pilot study.Cerebrovasc Dis,2001,12:308-12.
2Seitz RJ,Hanzavi M,Junghans U,et al.Thromblysis with recombinant tissue plasminogen activator and tirofiban in stroke:preliminary observations.Stroke,2003,34(8):1932-1935.
3Salvatore Mangiafico,Martino Cellerini,Patrizia Nencini,et al.Intravenous Glycoprotein IIb/IIIa Inhibitor (Tirofiban) followed by Intra-Arterial Urokinase and Mechanical Thrombolysis in Stroke.AJNR Am J Neuroradiol,2005,26:2595-2601.
4Deshmukh,Vivek R,Fiorella,David J,Albuquerque,Felipe C,et al.Intra-arterial Thrombolysis for Acute Ischemic Stroke:Preliminary Experience with Platelet Glycoprotein IIb/IIIa Inhibitors as Adjunctive Therapy.Neurosurgery,2005,56(1):46-55.
5Straub S,Junghans U,Jovanovic V,Wittsack HJ,Seitz RJ,Siebler M.Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion.Stroke,2004,35(3):705-709.
6Mangiafico S,Cellerini M,Nencini P,Gensini G,Inzitari D.Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke.AJNR Am J Neuroradiol,2005,26:2595-601.
7Haerten K,Krabbe C,Raiber M.Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice.Dtsch Med Wochenschr,2004,129(12):607-610.
8Alfonso Ciccone,Iosief Abraha,Ignazio Santilli.Glycoprotein IIb-IIIa Inhibitors for Acute Ischemic Stroke.Stroke,2007,38:1113-1114.
9Junghans U,Siebler M.Cerebral microembolism is blocked by tirofiban,a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist.Circulation,2003,107:2717-2721.
10Seitz RJ,Meisel S,Moll M,Wittsack HJ,Junghans U,Siebler M.The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions.Neurology,2004,62:2110-2.
